उत्पाद विवरण
Certican 0.75 mg Tablet is a targeted anticancer therapy indicated for the treatment of various advanced malignancies, including cancers of the pancreas, stomach, intestines, and lungs, particularly when surgical options are no longer viable. This medication is also effective for postmenopausal women battling advanced hormone receptor-positive breast cancer that is HER2-negative. In addition, Certican is utilized in adult patients with progressive kidney cancer following unsuccessful treatment with sunitinib or sorafenib. The active ingredient works by inhibiting specific pathways that allow cancer cells to proliferate, thereby slowing down disease progression. It is crucial to be aware of potential side effects, including increased risk of infection and liver enzyme alterations, which necessitate regular monitoring during treatment. Patients should discuss their full medical history with their healthcare provider to ensure safe use of Certican. This medication is best used as part of a comprehensive cancer management plan tailored to individual patient needs. Always consult your healthcare professional for personalized advice and guidance when considering Certican as part of your cancer treatment regimen.
Send Email 
जांच भेजें
जांच भेजें
एसएमएस भेजें
मुझे निःशुल्क कॉल करें
English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese